A Bivalent Human Norovirus Vaccine Induces Homotypic and Heterotypic Neutralizing Antibodies
The Journal of Infectious Diseases · 2024
DOI: 10.1093/infdis/jiad401 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Robert L Atmar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, Antibodies, Viral, Caliciviridae Infections, Norovirus. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Takeda Vaccines, Inc.
Abstract (Originalsprache)
A GII.2 outbreak in an efficacy study of a bivalent virus-like particle norovirus vaccine, TAK-214, in healthy US adults provided an opportunity to examine GII.4 homotypic vs GII.2 heterotypic responses to vaccination and infection. Three serologic assays—virus-like particle binding, histoblood group antigen blocking, and neutralizing—were performed for each genotype. Results were highly correlated within a genotype but not between genotypes. Although the vaccine provided protection from GII.2-associated disease, little GII.2-specific neutralization occurred after vaccination. Choice of antibody assay can affect assessments of human norovirus vaccine immunogenicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine.
- Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas.
- Department of Epidemiology, University of North Carolina, Chapel Hill.
- Takeda Vaccines Inc, Cambridge, Massachusetts.
- Takeda Pharmaceuticals International AG, Zurich, Switzerland.
ORCID-Profile: Robert L Atmar, Khalil Ettayebi, Sasirekha Ramani, Lisa Lindesmith, Ralph S Baric, Mary K Estes
Förderung
- Takeda Vaccines, Inc
Zitieren
APA
Atmar, R. L., Ettayebi, K., Ramani, S., Neill, F. H., Lindesmith, L., Baric, R. S., Brinkman, A., Braun, R., Sherwood, J., & Estes, M. K. (2024). A Bivalent Human Norovirus Vaccine Induces Homotypic and Heterotypic Neutralizing Antibodies. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad401
Vancouver
Atmar RL, Ettayebi K, Ramani S, Neill FH, Lindesmith L, Baric RS, et al. A Bivalent Human Norovirus Vaccine Induces Homotypic and Heterotypic Neutralizing Antibodies. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiad401
BibTeX
@article{Atmar2024,
author = {Atmar, Robert L and Ettayebi, Khalil and Ramani, Sasirekha and Neill, Frederick H and Lindesmith, Lisa and Baric, Ralph S and Brinkman, Amanda and Braun, Ralph and Sherwood, James and Estes, Mary K},
title = {A Bivalent Human Norovirus Vaccine Induces Homotypic and Heterotypic Neutralizing Antibodies},
journal = {The Journal of Infectious Diseases},
year = {2024},
doi = {10.1093/infdis/jiad401}
}
EUVIMED